Current position:Home >Product >
Diindolo[2',3':3,4]pyrido[2,1-a:2',1'-g][2,7]naphthyridine-7-carboxylicacid, 5,5b,6,6a,10,11,16,16b,16c,17,19,20-dodecahydro-16b-methyl-, methylester, (5bR,6aS,16bR,16cR)-
Diindolo[2',3':3,4]pyrido[2,1-a:2',1'-g][2,7]naphthyridine-7-carboxylicacid, 5,5b,6,6a,10,11,16,16b,16c,17,19,20-dodecahydro-16b-methyl-, methylester, (5bR,6aS,16bR,16cR)-(27773-33-7)
- Name: Diindolo[2',3':3,4]pyrido[2,1-a:2',1'-g][2,7]naphthyridine-7-carboxylicacid, 5,5b,6,6a,10,11,16,16b,16c,17,19,20-dodecahydro-16b-methyl-, methylester, (5bR,6aS,16bR,16cR)-
- Synonyms:Bisindolo[2',3':3,4]pyrido[2,1-a:2',1'-g][2,7]naphthyridine-7-carboxylicacid, 5,5b,6,6a,10,11,16,16b,16c,17,19,20-dodecahydro-16b-methyl-, methylester, (5bR,6aS,16bR,16cR)- (9CI); Roxburghine E (8CI); Roxburghine, (19b)-; 19-Epiroxburghine D;20-Epiroxburghine B;Bisindolo[2',3':3,4]pyrido[2,1-a:2',1'-g][2,7]naphthyridine-7-carboxylic acid,5,5b,6,6a,10,11,16,16b,16c,17,19,20-dodecahydro-16b-methyl-, methyl ester,[5bR-(5ba,6ab,16ba,16ca)]-
- Molecular Formula:C31H32 N4 O2
- Molecular Weight:
- CAS Registry Number:27773-33-7
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 90481-13-3/Phosphonic acid, reaction products with ammonia and formaldehyde, sodium salts
- 72379-31-8/Rubus idaeus extract
- 178174-17-9/7-((S)-3-Amino-1-pyrrolidinyl)-8-ethoxy-1-cyclopropyl-6-fluoro-1,4-dih ydro-4-oxoquinoline-3-carboxylic acid hydrochloride
- 13046-10-1/(Ethylenedinitrilo)tetrakis(methanesulfonic acid sodium) salt
- 36044-49-2/2H-CHROMENE-3-CARBOXYLIC ACID METHYL ESTER
- 80434-82-8/20-CARBOXY-LEUKOTRIENE B4
- 2363-37-3/1-(2-chlorophenoxy)-2,4-dinitrobenzene
- 92969-96-5/Nonanedioic acid, mono-C16-18-alkyl esters
- 128461-01-8/altromycin D
- 3034-38-6/4-Nitroimidazole
- 14939-17-4/germanyl hydrate
- 24327-08-0/ENDO-BICYCLO[2.2.2]OCT-5-ENE-2,3-DICARBOXYLIC ANHYDRIDE
- 30017-53-9/phenyl(triprop-2-en-1-yl)phosphonium bromide
- 86438-31-5/Olean-12-ene-23,28-dioic acid,3-(â-D-glucopyranuronosyloxy)-,28-â- D-glucopyranosyl ester,(3â,4R)-
- 149488-74-4/1-(5-methylpyridin-2-yl)-3-(2-pyridin-2-ylethyl)thiourea
- 38032-71-2/(+-)-5-Cyclohexyl-1-indanmethanol
- 160611-50-7/POLY(STYRENE-CO-MALEIC ACID), PARTIAL 2-BUTOXYETHYL ESTER, CUMENE TERMINATED
- 51489-69-1/bemosat
- 27773-33-7/Diindolo[2',3':3,4]pyrido[2,1-a:2',1'-g][2,7]naphthyridine-7-carboxylicacid, 5,5b,6,6a,10,11,16,16b,16c,17,19,20-dodecahydro-16b-methyl-, methylester, (5bR,6aS,16bR,16cR)-
- 22446-37-3/(2-HYDROXY-PHENYL)-ACETIC ACID METHYL ESTER
- 69895-69-8/4-(2-dimethylaminoethylamino)-1-hydroxy-anthracene-9,10-dione
- 17472-04-7/2-oxocyclohexyl acetate
- 4724-05-4/2-[(5-Heptyl-7-hydroxy-4-oxo-4H-1-benzopyran-2-yl)methyl]-4,6-dihydroxybenzoic acid
- 60550-88-1/N-(9H-fluoren-2-yl)cyclopropanecarboxamide
- 402-23-3/3-(Trifluoromethyl)benzyl bromide
- 83804-07-3/Sodium bis(4-hydroxy-3-((2-hydroxy-1-naphthyl)azo)-N-methylbenzenesulphonamidato(2-))cobaltate(1-)
- 123-44-4/2.2.4-TRIMETHYL-1-PENTANOL
- 38772-50-8/(3aR,7aS)-2-(2-hydroxyethyl)-3a,4,7,7a-tetrahydro-1H-isoindole-1,3(2H)-dione
- 16424-98-9/2-Heptylidene-1-cyclopentanone (2,4-dinitrophenyl)hydrazone
- 109006-05-5/N-{1-[4-(aminomethyl)benzyl]-2-oxo-2-pyrrolidin-1-ylethyl}naphthalene-2-sulfonamide